Institute: INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA

Doctor by the Universidad de Salamanca with the thesis Inhibition of shp1 and shp2 as a molecular targeted therapy against myeloid leukaemias 2019. Supervised by Dr. Ángel Hernández Hernández.